CXCL5 and lung carcinoma: Our findings collectively demonstrate that CXCL5 overexpression promotes immune escape and predicts a poor outcome in patients with lung cancer, indicating that CXCL5 may serve as a potential therapeutic target that could synergize with ICBs.